SYBX
SYNLOGIC, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.00
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 0.15x
- P/S forward
- 23.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.03x
- Price / sales
- —
- Price / cash flow
- -3.20x
Enterprise value
- Enterprise value
- -$863.8K
- EV / sales
- —
- EV / EBITDA
- 0.23x
- EV / EBIT
- 0.18x
- Market cap
- $12.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026